Company: TGNT
Filing Date: 2025-05-16
Form Type: 10-Q
Source: 0001477932-25-003912
Chunk: 18

Company: Totaligent, Inc.
Filing Date: 2025-05-16
Form: 10-Q
Item: Part I, Item 1
Chunk 18
---
 – 576,562 and 713,750 shares at March 31, 2025 and December 31, 2024, respectively  5,766   7,138 Common stock, $0.001 par value; authorized – 500,000,000 shares; 211,101,313 shares issued and 211,101,313 and 172,913,813 outstanding as of March 31, 2025 and December 31, 2024, respectively  211,101   211,101 Shares to be issued  5,476   5,476 Additional paid-in capital  990   818,577 Accumulated deficit  (2,126,063)  (1,807,363)Treasury stock, 0 and 38,187,500 outstanding  -   (972,181)Total stockholders' deficit  (1,902,730)  (1,737,252)Total liabilities and stockholders' deficit $349,573  $222,925 

The accompanying notes are an integral part of these unaudited consolidated financial statements 

 F-1Table of Contents

TOTALIGENT, INC.AND SUBSIDIARYCONSOLIDATED STATEMENTS OF OPERATIONSUNAUDITED

   For the Three Months Ended     March 31,     2025    2024         Revenue $-  $340,929          Cost of revenue  -   328,620          Gross profit  -   12,309          Operating expenses:        Consulting expenses  5,536   6,500 Personnel expenses  -   99,500 General and administrative  72,487   61,157 Total operating expenses  78,023   167,157          Net operating loss  (78,023)  (154,848)         Other income (expense)        Interest expense  (13,792)  (11,290)Amortization of debt discount  -   (5,659)Loss (gain) on change in fair value of derivative liability  (55,336)  43,907 Loss on disposal of assets  (18,327)  - Total other income (expense